Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.

Antimicrobial Agents and Chemotherapy
Jennifer M Adams-HaduchYohei Doi

Abstract

A total of 49 unique clinical isolates of multidrug-resistant (MDR) Acinetobacter baumannii identified at a tertiary medical center in Pittsburgh, Pennsylvania, between August 2006 and September 2007 were studied for the genetic basis of their MDR phenotype. Approximately half of all A. baumannii clinical isolates identified during this period qualified as MDR, defined by nonsusceptibility to three or more of the antimicrobials routinely tested in the clinical microbiology laboratory. Among the MDR isolates, 18.4% were resistant to imipenem. The frequencies of resistance to amikacin and ciprofloxacin were high at 36.7% and 95.9%, respectively. None of the isolates was resistant to colistin or tigecycline. The presence of the carbapenemase gene bla(OXA-23) and the 16S rRNA methylase gene armA predicted high-level resistance to imipenem and amikacin, respectively. bla(OXA-23) was preceded by insertion sequence ISAba1, which likely provided a potent promoter activity for the expression of the carbapenemase gene. The structure of the transposon defined by ISAba1 differed from those reported in Europe, suggesting that ISAba1-mediated acquisition of bla(OXA-23) may occur as an independent event. Typical substitutions in the quinolone...Continue Reading

References

May 1, 1995·Antimicrobial Agents and Chemotherapy·J VilaT Jimenez de Anta
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·C M Collis, R M Hall
Apr 1, 1996·Clinical Microbiology Reviews·E Bergogne-Bérézin, K J Towner
Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·J VilaT Jimenez de Anta
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John QualeRenuka Heddurshetti
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Marc GalimandThierry Lambert
Feb 3, 2005·FEMS Microbiology Letters·Heidi SegalB Gay Elisha
Feb 8, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Joel N MaslowMax Lataillade
Jul 20, 2005·The Journal of Antimicrobial Chemotherapy·Bruno González-ZornMiguel Angel Moreno
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert GaynesUNKNOWN National Nosocomial Infections Surveillance System
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Claire HéritierPatrice Nordmann
Jan 31, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C HéritierP Nordmann
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George H TalbotUNKNOWN Antimicrobial Availability Task Force of the Infectious Diseases Society of America
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·A RobicsekD C Hooper
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·Karen LolansJohn P Quinn
Sep 7, 2006·Antimicrobial Agents and Chemotherapy·Chi Hye ParkDavid C Hooper
Jan 16, 2007·Antimicrobial Agents and Chemotherapy·Stéphane CorvecPatrice Nordmann
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul ScottBruno Petruccelli
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yohei Doi, Yoshichika Arakawa
Jul 25, 2007·Antimicrobial Agents and Chemotherapy·Federico PerezRobert A Bonomo
Sep 6, 2007·Antimicrobial Agents and Chemotherapy·Yohei DoiDavid L Paterson
Jan 16, 2008·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Mar 21, 2008·The New England Journal of Medicine·L Silvia Munoz-Price, Robert A Weinstein
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson

❮ Previous
Next ❯

Citations

Jan 26, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S A DunhamA A Miller
Jul 9, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y ZhouM Wang
Apr 13, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mohammad AghazadehZoya Hojabri
Jun 26, 2010·The Journal of Antimicrobial Chemotherapy·Kumiko Kawamura-SatoYoshichika Arakawa
Mar 15, 2011·The Journal of Antimicrobial Chemotherapy·Yan ChenYunsong Yu
Jul 8, 2011·The Journal of Antimicrobial Chemotherapy·Andrea EndimianiVincent Perreten
Aug 31, 2011·Antimicrobial Agents and Chemotherapy·Zhihui ZhouYunsong Yu
Sep 23, 2009·Antimicrobial Agents and Chemotherapy·Vijaya Bharathi SrinivasanWondwossen A Gebreyes
Oct 24, 2012·Antimicrobial Agents and Chemotherapy·Rémy A BonninLaurent Poirel
Oct 14, 2009·Clinical Microbiology Reviews·Jacob StrahilevitzAri Robicsek
Sep 16, 2011·Journal of Clinical Microbiology·Jennifer M Adams-HaduchYohei Doi
Aug 27, 2010·Journal of Clinical Microbiology·Naomi RunnegarDavid L Paterson
Mar 20, 2009·Journal of Clinical Microbiology·Kristine M HujerRobert A Bonomo
Jun 18, 2009·Annals of Clinical Microbiology and Antimicrobials·Vijaya B SrinivasanWondwossen A Gebreyes
Dec 25, 2009·Emerging Infectious Diseases·Pauline D MugnierPatrice Nordmann
Mar 2, 2012·Emerging Infectious Diseases·Laurent PoirelPatrice Nordmann
Apr 9, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Saito HiguchiNaomasa Gotoh
Mar 27, 2015·Journal of Natural Science, Biology, and Medicine·Neetu GuptaRavindra Nath Mishra
Jun 12, 2013·Expert Review of Anti-infective Therapy·Rémy A BonninLaurent Poirel
Mar 29, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Dongguo WangJiayu Chen
Jun 4, 2013·Diagnostic Microbiology and Infectious Disease·Mohammad Ahangarzadeh RezaeeZoya Hojabri
Jul 31, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nabil KarahØrjan Samuelsen
Jan 13, 2016·The Journal of Antimicrobial Chemotherapy·Steven J Nigro, Ruth M Hall
Jan 22, 2011·Diagnostic Microbiology and Infectious Disease·Xiaohui WangXiaoju Lü
Mar 11, 2015·Scientific Reports·Shuru ZhouXuemin Guo
Oct 13, 2011·IUBMB Life·Laurent PoirelPatrice Nordmann
Nov 15, 2012·International Journal of Antimicrobial Agents·Louis Malone, Dong H Kwon
Dec 25, 2012·Journal of Medical Microbiology·Yuki Yamada, Akira Suwabe
Sep 13, 2015·Annals of Clinical Microbiology and Antimicrobials·Abdessalam CherkaouiJacques Schrenzel
Sep 11, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Yuriko FukutaYohei Doi
Apr 11, 2015·International Journal of Antimicrobial Agents·Anaïs PotronPatrice Nordmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.